BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND SMARCA4, hSNF2b, 6597, P51532, BRG1, SNF2L4, SNF2, SWI2, FLJ39786, BAF190, SNF2LB, SNF2-BETA, ENSG00000127616 AND Prognosis
10 results:

  • 1. [Clinical characteristics and prognosis analysis of 17 cases of smarca4-deficient chest tumors].
    Cao XN; Li Z; Wang QY
    Zhonghua Jie He He Hu Xi Za Zhi; 2024 Apr; 47(4):325-331. PubMed ID: 38599807
    [No Abstract]    [Full Text] [Related]  

  • 2. [Cytopathological characteristics of smarca4-deficient thoracic undifferentiated tumors in serous effusion].
    Wang WN; Liu XT; Liang YM
    Zhonghua Bing Li Xue Za Zhi; 2024 Feb; 53(2):143-148. PubMed ID: 38281781
    [No Abstract]    [Full Text] [Related]  

  • 3. A CIC-related-epigenetic factors-based model associated with prediction, the tumor microenvironment and drug sensitivity in osteosarcoma.
    Yu B; Geng C; Wu Z; Zhang Z; Zhang A; Yang Z; Huang J; Xiong Y; Yang H; Chen Z
    Sci Rep; 2024 Jan; 14(1):1308. PubMed ID: 38225273
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Characterization of a Preclinical In Vitro Model Derived from a smarca4-Mutated Sinonasal Teratocarcinosarcoma.
    Lorenzo-Guerra SL; Codina-Martínez H; Suárez-Fernández L; Cabal VN; García-Marín R; Riobello C; Vivanco B; Blanco-Lorenzo V; Sánchez-Fernández P; López F; Llorente JL; Hermsen MA
    Cells; 2023 Dec; 13(1):. PubMed ID: 38201285
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Osteosarcoma's genetic landscape painted by genes' mutations.
    Urban W; Krzystańska D; Piekarz M; Nazar J; Jankowska A
    Acta Biochim Pol; 2023 Sep; 70(3):671-678. PubMed ID: 37717265
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. ZNF384-Related Fusion Genes in Acute Lymphoblastic Leukemia.
    Zhu L; Bai W; Cheng Q; Fang J
    Cancer Control; 2023; 30():10732748231182787. PubMed ID: 37306722
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Thoracic smarca4-deficient undifferentiated tumor resembling malignant lymphoma].
    Asou C; Maeda T; Yamaguchi O; Okamura D; Ishikawa M; Kohri M; Tsukasaki K; Matsuda A; Asou N; Satoh T; Kayano H; Takahashi N
    Rinsho Ketsueki; 2023; 64(4):271-276. PubMed ID: 37121771
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. NUT carcinoma of the lung.
    Lantuejoul S; Pissaloux D; Ferretti GR; McLeer A
    Semin Diagn Pathol; 2021 Sep; 38(5):72-82. PubMed ID: 34176698
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia.
    Fabiani E; Cicconi L; Nardozza AM; Cristiano A; Rossi M; Ottone T; Falconi G; Divona M; Testi AM; Annibali O; Castelli R; Lazarevic V; Rego E; Montesinos P; Esteve J; Venditti A; Della Porta M; Arcese W; Lo-Coco F; Voso MT
    Cancer Med; 2021 Jun; 10(12):3839-3847. PubMed ID: 34042280
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Proline‑rich polypeptide‑1 decreases cancer stem cell population by targeting BAFF chromatin‑remodeling complexes in human chondrosarcoma JJ012 cells.
    Moran A; Hoyt A; Sedani A; Granger C; Saigh S; Blonska M; Zhao-Ju L; Conway SA; Pretell J; Brown J; Galoian K
    Oncol Rep; 2020 Jul; 44(1):393-403. PubMed ID: 32627042
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.